P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts
- PMID: 15722352
- DOI: 10.1074/jbc.M410764200
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts
Abstract
Nucleotides, released from cells during inflammation and by mechanical stimulation, act through the P2 family of nucleotide receptors. Previous studies have demonstrated the expression of P2Y1 and P2Y2 receptors in osteoclasts. The aim of this study was to determine whether osteoclast P2Y receptors signal through NF-kappaB, a key transcription factor regulating osteoclastogenesis. Immunofluorescence was used to detect the p65 subunit of NF-kappaB, which upon activation translocates from the cytosol to nuclei. Low levels of NF-kappaB activation were observed in untreated rabbit osteoclasts and in those exposed to 2-methylthio ADP (P2Y1 agonist) or ATP or UTP (P2Y2 agonists). In contrast, UDP or INS48823 (P2Y6 agonists) induced a significant increase in the number of cells exhibiting NF-kappaB activation, a process sensitive to the proteasome inhibitor lactacystin. In osteoclasts purified by micromanipulation, reverse transcription-PCR revealed the presence of P2Y1, P2Y2, and P2Y6 receptor transcripts, and application of agonists for these receptors induced the transient rise of cytosolic calcium. Treatment of rat osteoclasts with UDP or INS48823, but not 2-methylthio ADP or UTP, increased osteoclast survival. Osteoprotegerin (a decoy receptor for RANK ligand) did not significantly alter the effects of UDP on NF-kappaB localization or osteoclast survival, consistent with a direct action. Moreover, SN50 (cell-permeable peptide inhibitor of NF-kappaB) suppressed the enhancement of cell survival induced by UDP and INS48823. Our findings demonstrate the presence of functional P2Y6 receptors in osteoclasts. Thus, nucleotides, following their release at sites of inflammation and mechanical stimulation, can act through P2Y6 receptors to initiate NF-kappaB signaling and enhance osteoclast survival.
Similar articles
-
Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts.J Bone Miner Res. 2004 Apr;19(4):642-51. doi: 10.1359/JBMR.040108. Epub 2004 Jan 5. J Bone Miner Res. 2004. PMID: 15005852
-
Purinergic P2Y6 receptors induce Ca2+ and CFTR dependent Cl- secretion in mouse trachea.Cell Physiol Biochem. 2005;16(1-3):99-108. doi: 10.1159/000087736. Cell Physiol Biochem. 2005. PMID: 16121038
-
The activation of P2Y6 receptor in cultured spinal microglia induces the production of CCL2 through the MAP kinases-NF-κB pathway.Neuropharmacology. 2013 Dec;75:116-25. doi: 10.1016/j.neuropharm.2013.07.017. Epub 2013 Aug 2. Neuropharmacology. 2013. PMID: 23916475
-
Molecular pharmacology of P2Y-receptors.Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):310-23. doi: 10.1007/s002100000310. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 11111826 Review.
-
P2 receptor expression, signaling and function in osteoclasts.Front Biosci (Schol Ed). 2011 Jun 1;3(3):1101-18. doi: 10.2741/214. Front Biosci (Schol Ed). 2011. PMID: 21622259 Review.
Cited by
-
Changes in P2Y6 receptor-mediated vasoreactivity following focal and global ischemia.Physiol Rep. 2022 Apr;10(8):e15283. doi: 10.14814/phy2.15283. Physiol Rep. 2022. PMID: 35466569 Free PMC article.
-
Activation of extracellular-signal regulated kinase (ERK1/2) by fluid shear is Ca(2+)- and ATP-dependent in MC3T3-E1 osteoblasts.Bone. 2008 Apr;42(4):644-52. doi: 10.1016/j.bone.2007.09.058. Epub 2007 Oct 16. Bone. 2008. PMID: 18291742 Free PMC article.
-
Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor.Purinergic Signal. 2016 Jun;12(2):199-209. doi: 10.1007/s11302-015-9492-1. Epub 2016 Jan 8. Purinergic Signal. 2016. PMID: 26746211 Free PMC article.
-
Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.Mol Endocrinol. 2012 Jan;26(1):142-52. doi: 10.1210/me.2011-1083. Epub 2011 Nov 22. Mol Endocrinol. 2012. PMID: 22108801 Free PMC article.
-
The P2X7 Receptor is an Important Regulator of Extracellular ATP Levels.Front Endocrinol (Lausanne). 2012 Mar 19;3:41. doi: 10.3389/fendo.2012.00041. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22654865 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases